Stanislas Veillet
Chief Executive Officer bei BIOPHYTIS S.A.
Vermögen: 123 891 $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Stanislas Veillet
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Other | 23 | |
12
| Public Company | Aerospace & Defense | 12 |
Biophytis, Inc.
Biophytis, Inc. Pharmaceuticals: MajorHealth Technology Part of Biophytis SA, Biophytis, Inc. operates as a clinical-stage biotechnology company which develops therapeutics for aging and improving functional outcomes. The private company is based in Newark, DE.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stanislas Veillet
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Comptroller/Controller/Auditor | |
BIODESIX, INC. | Medical/Nursing Services | Director/Board Member | |
GUERBET | Medical Specialties | Chairman | |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
CYBERGUN | Recreational Products | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
UMR, Inc.
UMR, Inc. Miscellaneous Commercial ServicesCommercial Services UMR, Inc. provides employee benefit plan administration for self-funded employers. The company provices health, disability, flexible spending accounts, stop loss, pharmacy benefits, COBRA, HIPAA, dental, vision and medical management services. It also provides medical management services and BirthLine4, a pregnancy education and health assessment program. Wausau Benefits is headquartered in Wausau, WI. | Miscellaneous Commercial Services | Director/Board Member | |
Hofstra University | College/University | Undergraduate Degree | |
Tulane University (Louisiana) | College/University | Undergraduate Degree | |
New York University | College/University | Undergraduate Degree | |
University of Amsterdam | College/University | Masters Business Admin | |
MEDIAN TECHNOLOGIES | Medical/Nursing Services | Director of Finance/CFO | |
University of Utrecht | College/University | Doctorate Degree | |
École Normale Supérieure | College/University | Undergraduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Graduate Degree | |
International Institute of New England, Inc.
International Institute of New England, Inc. Services to the Health IndustryHealth Services International Institute of New England, Inc. operates as a non-profit organization serving immigrants, refugees, asylees, and other vulnerable populations. Its services include refugee resettlement, case management, health services navigation, employment, education and literacy and citizenship programming. The company was founded in 1910 and is headquartered in Boston, MA. | Services to the Health Industry | Director/Board Member | |
École Supérieure Libre des Sciences Commerciales Appliquées | College/University | Masters Business Admin | |
bioMérieux, Inc.
bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | Medical Specialties | Corporate Officer/Principal | |
VISIONEERING TECHNOLOGIES, INC. | Electronic Components | Director/Board Member | |
Cargill France SAS
Cargill France SAS Agricultural Commodities/MillingProcess Industries Cargill France SAS engages in trading corn and soy flours. It also provides meat and chicken processing, chocolate and food ingredients. The company was founded in 1964 and is headquartered in Saint-Germain-en-Laye, France. | Agricultural Commodities/Milling | Corporate Officer/Principal | |
Institut Français Des Administrateurs
Institut Français Des Administrateurs Miscellaneous Commercial ServicesCommercial Services Institut Français Des Administrateurs is a private company based in Paris, France. The French company promotes governance and develops leadership skills. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ROTH Mions SAS
ROTH Mions SAS Industrial MachineryProducer Manufacturing ROTH Mions SAS manufactures hydro pneumatic accumulator shells and cylinders. Its products include bottles diving, accumulators, and specific products. The company was founded in 1975 and is headquartered in Mions, France. | Industrial Machinery | Director/Board Member Director/Board Member Director/Board Member | |
AgroParisTech | College/University | Undergraduate Degree | |
BIOM'UP | Medical Specialties | Director of Finance/CFO Director/Board Member | |
Théâtre du Châtelet
Théâtre du Châtelet Movies/EntertainmentConsumer Services Théâtre du Châtelet operates theatre and opera house. It hosts a variety of art forms such as ballet, opera, operetta, musicals and cinema. The company was founded on August 19, 1862 and is headquartered in Paris, France. | Movies/Entertainment | Chairman | |
Université d'Aix-Marseille | College/University | Doctorate Degree | |
Roman Toys SA | Chief Executive Officer | ||
METASTAT, INC. | Electrical Products | Comptroller/Controller/Auditor | |
KEDGE Business School | College/University | Masters Business Admin | |
DIMENSION THERAPEUTICS INC | Biotechnology | Director of Finance/CFO | |
Cybergun Italia SRL | Chief Executive Officer Chief Executive Officer | ||
Khondrion BV
Khondrion BV Pharmaceuticals: MajorHealth Technology Khondrion BV is a Dutch clinical-stage biopharmaceutical company that focuses on discovering and developing therapies for mitochondrial diseases. The company is based in Nijmegen, Netherlands, and was founded in 2012 by Jan Smeitink, who has been the CEO since then. The company's lead drug candidate, sonlicromanol, is a first-in-class, oral small molecule that targets key underlying mechanisms of primary mitochondrial disease. The compound has been granted orphan drug designations for the treatment of various mitochondrial diseases. Khondrion collaborates with a clinical and academic network and patient organizations internationally to accelerate the discovery and development of its potential medicines. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Institut De Recherche Et D'Innovation Scientifique SARL | Founder | ||
Laboratoire Nature Et Technique SARL | Founder | ||
REPLIMUNE GROUP, INC. | Biotechnology | Director of Finance/CFO | |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Director/Board Member | |
Hellébore SAS | Chairman | ||
Aerial Group BV
Aerial Group BV Aerospace & DefenseElectronic Technology Aerial Group BV engages in the design and manufacture of drones for civilian uses. It specializes in character recognition, thermal, person recognition, censoring, component identification, and face mask detection software. The firm serves the safety and security, inspection, surveying and mapping, agriculture, and research industries. The company was founded by Lucas van Oostrum and Robin van de Putte and is headquartered in Katwijk, the Netherlands. | Aerospace & Defense | Chief Operating Officer | |
Fj Immo SARL | Corporate Officer/Principal | ||
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member | |
Bioval Technologies di Stefano Valentini | Corporate Officer/Principal | ||
Université Paris-Saclay | College/University | Doctorate Degree | |
VectorY BV
VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Society for Research on the Cerebellum & Ataxias | President | ||
DISC MEDICINE, INC. | Biotechnology | Director of Finance/CFO | |
Good Start Genetics, Inc.
Good Start Genetics, Inc. Medical/Nursing ServicesHealth Services Good Start Genetics, Inc. operates as a molecular diagnostics firm. It offers pre-pregnancy diagnostic test services to screen a panel of genetic disorders. The firm also provides clinical laboratory and genetic counseling support services. The company was founded by Eric Boutin, Paris Wallace, and Gregory J. Porreca in December 2007 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director of Finance/CFO |
Statistik
International
Frankreich | 24 |
Vereinigte Staaten | 17 |
Niederlande | 6 |
Schweiz | 4 |
Belgien | 3 |
Sektoral
Consumer Services | 15 |
Health Technology | 13 |
Health Services | 6 |
Commercial Services | 5 |
Electronic Technology | 3 |
Operativ
Director/Board Member | 49 |
Corporate Officer/Principal | 41 |
Director of Finance/CFO | 23 |
Chief Tech/Sci/R&D Officer | 21 |
Independent Dir/Board Member | 20 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Stanislas Veillet
- Unternehmensverbindungen